Mechanisms and clinical impact of antifungal drug resistance
Authors:
- D.W. WarnockDWD.W. Warnock
- B. DupontBDB. Dupont
- D. KerridgeDKD. Kerridge
- S. Sen GuptaSGS. Sen Gupta
- L. ImprovisiLIL. Improvisi
- P. MarichalPMP. Marichal
- F.C. OddsFOF.C. Odds
- F. ProvostFPF. Provost
- O. RoninORO. Ronin
- 1 January 1994
- journal article
- review article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 32 (s1) , 189-202
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1Antimicrobial Agents and Chemotherapy, 1993
- Prophylactic Fluconazole andCandida kruseiInfectionsNew England Journal of Medicine, 1992
- Emergence ofCandida krusei infections after therapy of oropharyngeal candidiasis with fluconazoleEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Prophylactic oral fluconazole and candida fungaemiaThe Lancet, 1991
- Uptake of pyrimidines and their derivatives into Candida glabrata and Candida albicansJournal of General Microbiology, 1990
- Pathogenicity of 5-fluorocytosine resistant strains ofCandida albicansMedical Mycology, 1990
- Isolation and Characterization of Fluoropyrimidine‐Resistant Mutants in Two Candida SpeciesAnnals of the New York Academy of Sciences, 1988
- Incidence of polyene-resistant yeasts recovered from clinical specimensAntimicrobial Agents and Chemotherapy, 1980
- Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte functionThe American Journal of the Medical Sciences, 1978
- The Development Of Resistance By Candida Species To Polyene Antibiotics In VitroJournal of Medical Microbiology, 1971